Association Between Prescription Opioid Misuse and Risky Health Behaviors Among High School Students in the U.S.: A Cross-Sectional Study 2017–2021
Abstract
Objective: The objective of this study was to investigate the association between prescription opioid misuse and 18 risky health behaviors among high school students in the United States.
Material and Methods: This study utilized the most recent 2017, 2019, and 2021 Youth Risk Behavior Surveillance System (YRBSS) nationally representative data of n=44,329 high school students (Grades 9-12). We created 2 groups based on participants who reported lifetime prescription opioid misuse and those who did not. Bivariate analysis included Pearson’s chi-squared tests to compare the baseline differences between the 2 groups. For multivariate analysis, a survey-weighted logistic regression model, which adjusted for socio-demographic factors, was used to explore the association between prescription opioid misuse and selected risky health behaviors.
Results: The adjusted multivariate model showed a significant association between prescription opioid misuse and risky health behaviors related to driving, suicidal ideation, and illicit substance use. Significant associations were found between prescription opioid misuse and suicidal ideation, which included feelings of hopelessness and seriously considering suicide. However, no significant relationship was observed between making plans for suicide and attempting suicide.
Conclusion: The findings highlight that high school students with a history of prescription opioid misuse engaged in other adverse health behaviors. Public health policymakers should consider these findings in order to take a multifaceted approach by working with teachers, counselors, and clinicians to create programs to assist the high school students who are part of this high-risk population.
Keywords
Full Text:
PDFReferences
Kuehn BM. Massive costs of the US opioid epidemic in lives and dollars. JAMA 2021;325:2040.
Duchovny N, Mutter R. The opioid crisis and recent federal policy responses. [homepage on the Internet]. Washington, D.C.: Congressional Budget Office; 2022 [cited 2024 Nov 19]. Available from: https://www.cbo.gov/publication/58221.
American Medical Association. Overdose Epidemic Report 2023: Physicians’ actions to help end the nation’s drug-related overdose and death epidemic—and what still needs to be done [monograph on the Internet]. Chicago: American Medical Association; 2023 [cited 2024 Nov 19]. Available from: https://end-overdose-epidemic.org/wp-content/uploads/2023/11/23-894446-Advocacy-2023-overdose-report_FINAL.pdf.
Spencer MR, Miniño AM, Warner M. Drug Overdose Deaths in the United States, 2002–2022. National Center for Health Statistics Data Brief No. 491. Hyattsville, MD: National Center for Health Statistics; 2024. https://stacks.cdc.gov/view/cdc/135849
Currie J, Schwandt H. The opioid epidemic was not caused by economic distress but by factors that could be more rapidly addressed. Ann Am Acad Pol Soc Sci 2021;695:276-91.
Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health 2018;108:182-6.
Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Pub health 2015;36:559-74.
Baiden P, Eugene DR, Nicholas JK, Spoor S, Brown FA, LaBrenz CA. Misuse of prescription opioids and suicidal behaviors among Black adolescents: findings from the 2017 and 2019 youth risk behavior survey. J Racial Ethn Health Disparities 2023;10:1856-68.
Bhatia D, Mikulich-Gilbertson SK, Sakai JT. Prescription opioid misuse and risky adolescent behavior. Pediatrics 2020;145.
US Department of Health and Human Services. Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington, DC: HHS; 2016.
Centers for Disease Control and Prevention. High-risk substance use in youth. [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention; 2022 [cited 2024 Nov 19]. Available from: https://www.cdc.gov/healthyyouth/substance-use/index.html
Miech R, Johnston L, O’Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics 2015;136:e1169-77.
Clayton HB, Bohm MK, Lowry R, Ashley C, Ethier KA. Prescription opioid misuse associated with risk behaviors among adolescents. Am J Prev Med 2019;57:533-9.
Clayton HB, Lowry R, Basile KC, Demissie Z, Bohm MK. Physical and sexual dating violence and nonmedical use of prescription drugs. Pediatrics 2017;140.
Connolly S. Characteristics of alcohol, marijuana, and other drug use among persons aged 13–18 years being assessed for substance use disorder treatment—United States, 2014–2022. MMWR Morb Mortal Wkly Rep 2024;73.
Jenkins RA. The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective. Prev Med 2021;152:106541.
Rawson RA, Erath TG, Clark HW. The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl. Prev Med 2023;17:107625.
Curtin SC, Garnett MF. Suicide and homicide death rates among youth and young adults aged 10–24: United States, 2001–2021. NCHS Data Brief 2023;:1–8.
Centers for Disease Control and Prevention (CDC). 2017 YRBS data user’s guide. [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention; 2017 [cited 2024 Nov 11]. Available from: https://www.cdc.gov/healthyyouth/data/yrbs/pdf/2017/2017_YRBS_Data_Users_Guide.pdf.
Centers for Disease Control and Prevention (CDC). 2019 YRBS data user’s guide [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention; 2019 [cited 2024 Nov 11]. Available from: https://www.cdc.gov/healthyyouth/data/yrbs/pdf/2019/2019_National_YRBS_Data_Users_Guide.pdf
Centers for Disease Control and Prevention (CDC). 2021 YRBS data user’s guide. [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention; 2021 [cited 2024 Nov 11]. Available from: https://www.cdc.gov/healthyyouth/data/yrbs/pdf/2021/2021_YRBS_Data_Users_Guide_508.pdf.
O’Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant 2007;41:673-90.
Jones CM. Prescription opioid misuse and use of alcohol and other substances among high school students—Youth Risk Behavior Survey, United States, 2019. MMWR Suppl 2020;69(Suppl 1):38–46.
Lumley T. Analysis of complex survey samples. J Stat Softw 2004;9:1–9. doi: 10.18637/jss.v009.i08.
Underwood JM, Brener N, Thornton J, Harris WA, Bryan LN, Shanklin SL, et al. Overview and methods for the youth risk behavior surveillance system-United States, 2019. MMWR Suppl 2020;69:1-10.
Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 2021;34:344-50.
Gladden RM. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 states, July–December 2017 to January–June 2018. MMWR Morb Mortal Wkly Rep 2019;68:737–44.
Wilkins NJ, Clayton H, Jones CM, Brown M. Current prescription opioid misuse and suicide risk behaviors among high school students. Pediatrics 2021;147.
Cragg A, Hau JP, Woo SA, Kitchen SA, Liu C, Doyle-Waters MM, Hohl CM. Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis. Ann Emerg Med 2019;74:634-46.
Yang Y. Lifetime use of multiple substances and youth suicide risk: assessing the role of depressive symptoms using structural equation modeling. Pub Health 2024;234:71-6.
Jones SE, Brener ND, Queen B, Hershey-Arista M, Harris WA, Mpofu JJ, et al. Reliability of the 2021 national youth risk behavior survey questionnaire. Am J Health Promot 2024;38:843-51.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.